Multinodular goitre

Published on 02/04/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1214 times

140 Multinodular goitre

Questions

What are the treatment options available for non-toxic multinodular goitre?

Surgery is the standard therapy, especially when rapid decompression of vital structures is required. It allows pathological examination of the thyroid. Disadvantages include postoperative tracheal obstruction, recurrent laryngeal nerve injury, hypoparathyroidism, hypothyroidism and goitre recurrence.

Thyroxine therapy to shrink goiters is no longer recommended. Disadvantages are that it causes only a small decrease in thyroid volume; long-term efficacy is not known; it causes a decrease in bone mineral density in postmenopausal women; and there are possible cardiac side effects.

Radioiodine is an alternative to surgery in elderly patients and in those with cardiopulmonary disease. It results in a substantial decrease in thyroid volume and improvement of compressive symptoms in most patients. Disadvantages are that it only causes a gradual decrease in thyroid volume; radiation thyroiditis (usually mild) and radiation-induced thyroid dysfunction (hyperthyroidism in 5%, hypothyroidism in 20–30%) ) can occur; and there is a possible risk of radiation-induced cancer (N Engl J Med 1998;338:1438–47).

Treatment options depends on the nodule:

Advanced-level questions

How do you differentiate between Graves’ disease and toxic nodular goitre?

Graves’ disease Toxic nodular goitre
Younger age group Older individuals
Diffuse goitre Nodular enlargement of the gland
Eye signs common Eye signs are rare
Atrial fibrillation is uncommon Atrial fibrillation is common (about 40% of the patients)
Other autoimmune diseases are common Other autoimmune diseases are uncommon